Lyra Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.73

-0.02 (-2.67%)

As of May 9, 9:49 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,817.8% upside

Low Target $9.32

Average Target $14.00

High Target $16.42

Current Price $0.73

Current
$0.73

Target
$14.00

$9.32 $14.00 avg $16.42

Scenario Analysis

Bear Case

$9.32

1,176.7%

Low target

Base Case

$14.00

+1,817.8%

Avg target

Bull Case

$16.42

+2,149.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

Target vs 52W High

$14.00

-62.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%